Granted Patent
B2
US 7,825,107 · App. 11/751,846 · Granted Nov 2, 2010
Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A method for treatment or prevention of chronic nonbacterial prostatitis in individuals without urethral sphincter dysfunction, comprises administering an effective amount of (i) a selective estrogen receptor modulator (SERM) having estrogen antagonist effect in the prostate, (ii) an aromatase inhibitor, and/or (iii) an antiestrogen.
Claims (2)
1. A method of treating chronic nonbacterial prostatitis in men, comprising administering to a patient in need thereof an effective amount of fispemifene wherein said chronic nonbacterial prostatitis is not associated with urethral sphincter dysfunction.
2. The method of claim 1 , comprising the step of administering fispemifene in an amount in a range of about 0.1 to about 100 mg/kg of body weight.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 18, 2013
From: HALONEN, KAIJA
To: HORMOS MEDICAL LTD.
Reel/Frame 030631/0791 →
RELEASE OF SECURITY INTEREST
Recorded Mar 11, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL INC.
To: QUATRX PHARMACEUTICALS COMPANY
Reel/Frame 029963/0829 →
SECURITY AGREEMENT
Recorded Apr 24, 2009
From: QUATRX PHARMACEUTICALS COMPANY
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 022584/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 10, 2007
From: SANTTI, RISTO; STRENG, TOMI; BERNOULLI, JENNI; YATKIN, EMRAH
To: HORMOS MEDICAL LTD
Reel/Frame 019966/0310 →